---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-012431"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2023-04-17T23:59:59+00:00"
generated_at: "2026-06-17T01:20:17.505360+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GlucoTrack closes $10M public offering of common stock and pre-funded warrants

## Summary
- Gross proceeds of ~$10.0M from firm commitment offering; 7,352,942 shares and pre-funded warrants sold at $1.36/unit.
- Underwriting agreement signed April 13, 2023; Aegis Capital Corp. acted as sole book-running manager.
- Net proceeds allocated to working capital, general corporate purposes, including potential acquisitions and sales/marketing.
- Offering conducted under effective S-3 shelf registration (No. 333-259664); prospectus supplement filed with SEC.

## SEC filing metadata
- accession: 0001493152-23-012431
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2023-04-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315223012431/0001493152-23-012431-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315223012431/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-012431
- JSON: https://secwatch.observer/filing/0001493152-23-012431.json
- Plain text: https://secwatch.observer/filing/0001493152-23-012431.txt

## Key facts
- Material Agreements
  Glucotrack, Inc. entered into a underwriting with Aegis Capital Corp. valued at approximately $10.0 million (effective 2023-04-13).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Aegis Capital Corp.
  - Value: approximately $10.0 million
  - Effective: 2023-04-13
  source text: ompany entered into an underwriting agreement with Aegis Capital Corp. on April 13, 2023. The Company intends to use the net proceeds from this offering primarily for working capital and general corporate purposes, which may include,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1506983/000149315223012431/0001493152-23-012431-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.